Kinetics of appearance of differentiation-associated characteristics in ML-1, a line of human myeloblastic leukemia cells, after treatment with 12-O-tetradecanoylphorbol-13-acetate, dimethyl sulfoxide or 1-beta-D-arabinofuranosylcytosine

Cancer Res. 1982 Dec;42(12):5152-8.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Cell Cycle / drug effects
  • Cell Differentiation / drug effects
  • Cell Line
  • Cell Survival / drug effects
  • Dimethyl Sulfoxide / pharmacology*
  • Humans
  • Kinetics
  • Leukemia, Myeloid, Acute / physiopathology*
  • Phorbols / pharmacology*
  • Tetradecanoylphorbol Acetate / pharmacology*
  • Vidarabine / pharmacology*

Substances

  • Phorbols
  • Vidarabine
  • Tetradecanoylphorbol Acetate
  • Dimethyl Sulfoxide